会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • Power device and safety control method thereof
    • 电力设备及其安全控制方法
    • US09217578B2
    • 2015-12-22
    • US13067899
    • 2011-07-05
    • Su Ho JoKwan Joo MyoungJi Eun LeeO Do Ryu
    • Su Ho JoKwan Joo MyoungJi Eun LeeO Do Ryu
    • H04B3/00F24F11/00
    • F24F11/006F24F11/30F24F11/54F24F11/62H04B3/548H04B3/56H04B2203/5416H04B2203/5445H04B2203/5458
    • An air conditioner includes at least one indoor unit and a wired controller connected to the indoor unit through two lines to receive power from the indoor unit and to perform data communication with the indoor unit. Each of the indoor unit and the wired controller includes a communication unit that modulates a low-frequency communication signal into a high-frequency communication signal and transmits the high-frequency signal and demodulates a received high-frequency signal into a low-frequency signal. When a plurality of indoor units and a wired controller perform communication, a communication signal is transmitted after being modulated into a high-frequency signal and linking the high-frequency signal with DC power. This reduces the inductance of an inductor required to separate the linked high-frequency signal into DC power and a communication signal and the capacitance of a capacitor required to link the signal with DC power, reducing PCB size and inductor and capacitor costs.
    • 空调器包括至少一个室内单元和有线控制器,其通过两条线连接到室内单元,以从室内单元接收电力并与室内单元进行数据通信。 室内单元和有线控制器中的每一个包括将低频通信信号调制成高频通信信号的通信单元,并将高频信号发送并将接收到的高频信号解调为低频信号。 当多个室内单元和有线控制器进行通信时,通信信号在被调制成高频信号并将高频信号与直流电力连接之后被发送。 这降低了将链接的高频信号分离成直流电力所需的电感器的电感,以及将信号与直流电力连接所需的通信信号和电容器的电容,从而降低PCB尺寸和电感器和电容器成本。
    • 7. 发明授权
    • VCAM-1 specific monoclonal antibody
    • VCAM-1特异性单克隆抗体
    • US07655417B2
    • 2010-02-02
    • US11756437
    • 2007-05-31
    • Junho ChungJi Eun LeeEun Kyung RyuSukmook Lee
    • Junho ChungJi Eun LeeEun Kyung RyuSukmook Lee
    • G01N33/53C12N15/87C12P21/06C07K16/00C07K16/28
    • C07K16/2836C07K2317/55C07K2319/30
    • The present invention relates to a monoclonal antibody that specifically binds to vascular cell adhesion molecule-1 (VCAM-1 or CD106). Specifically, the present invention relates to an antibody that specifically binds to both human and mouse vascular cell adhesion molecule-1 (VCAM-1), a method for producing the same, a composition for diagnosis or treatment comprising them and a method for diagnosis or treatment using them. The monoclonal antibody of the present invention is the first recombinant monoclonal antibodies that is specific to human and mouse VCAM-1. In addition, the monoclonal antibody of the present invention shows a strong affinity to VCAM-1 expressed in rat skeletal muscle and porcine endothelial cells as well as human and mouse endothelial cells and is found to strongly inhibit the interaction between leukocytes and activated endothelial cells. Accordingly, the monoclonal antibody of the present invention can inhibit a VCAM-1 mediated adhesion of leukocytes to endothelial cells and potently treat VCAM-1 mediated disease, especially inflammatory disease or cancer.
    • 本发明涉及特异性结合血管细胞粘附分子-1(VCAM-1或CD106)的单克隆抗体。 具体地,本发明涉及特异性结合人和小鼠血管细胞粘附分子-1(VCAM-1)的抗体,其制备方法,包含它们的诊断或治疗组合物以及诊断或诊断方法 治疗使用它们。 本发明的单克隆抗体是人和小鼠VCAM-1特异性的第一种重组单克隆抗体。 此外,本发明的单克隆抗体显示出对大鼠骨骼肌和猪内皮细胞以及人和小鼠内皮细胞中表达的VCAM-1的强亲和力,并且发现其强烈抑制白细胞和活化的内皮细胞之间的相互作用。 因此,本发明的单克隆抗体可以抑制VCAM-1介导的白细胞对内皮细胞的粘附,并且有效治疗VCAM-1介导的疾病,特别是炎性疾病或癌症。
    • 9. 发明申请
    • VCAM-1 SPECIFIC MONOCLONAL ANTIBODY
    • VCAM-1特异性单克隆抗体
    • US20070280941A1
    • 2007-12-06
    • US11756437
    • 2007-05-31
    • Junho ChungJi Eun LeeEun Kyung RyuSukmook Lee
    • Junho ChungJi Eun LeeEun Kyung RyuSukmook Lee
    • A61K39/395C07K16/28
    • C07K16/2836C07K2317/55C07K2319/30
    • The present invention relates to a monoclonal antibody that specifically binds to vascular cell adhesion molecule-1 (VCAM-1 or CD106). Specifically, the present invention relates to an antibody that specifically binds to both human and mouse vascular cell adhesion molecule-1 (VCAM-1), a method for producing the same, a composition for diagnosis or treatment comprising them and a method for diagnosis or treatment using them. The monoclonal antibody of the present invention is the first recombinant monoclonal antibodies that is specific to human and mouse VCAM-1. In addition, the monoclonal antibody of the present invention shows a strong affinity to VCAM-1 expressed in rat skeletal muscle and porcine endothelial cells as well as human and mouse endothelial cells and is found to strongly inhibit the interaction between leukocytes and activated endothelial cells. Accordingly, the monoclonal antibody of the present invention can inhibit a VCAM-1 mediated adhesion of leukocytes to endothelial cells and potently treat VCAM-1 mediated disease, especially inflammatory disease or cancer.
    • 本发明涉及特异性结合血管细胞粘附分子-1(VCAM-1或CD106)的单克隆抗体。 具体地,本发明涉及特异性结合人和小鼠血管细胞粘附分子-1(VCAM-1)的抗体,其制备方法,包含它们的诊断或治疗组合物以及诊断或诊断方法 治疗使用它们。 本发明的单克隆抗体是对人和小鼠VCAM-1特异的第一种重组单克隆抗体。 此外,本发明的单克隆抗体显示出对大鼠骨骼肌和猪内皮细胞以及人和小鼠内皮细胞中表达的VCAM-1的强亲和力,并且发现其强烈抑制白细胞和活化的内皮细胞之间的相互作用。 因此,本发明的单克隆抗体可以抑制VCAM-1介导的白细胞对内皮细胞的粘附,并且有效治疗VCAM-1介导的疾病,特别是炎性疾病或癌症。